European Patent Office

T 0867/23 (Cariprazine for treating primary negative symptoms of schizophrenia / RICHTER GEDEON NYRT.) of 21.01.2025

European Case Law Identifier
ECLI:EP:BA:2025:T086723.20250121
Date of decision
21 January 2025
Case number
T 0867/23
Petition for review of
-
Application number
13805597.5
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Application title
TRANS-4-{2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL}-N,N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR TREATING PRIMARY NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
Applicant name
Richter Gedeon Nyrt.
Opponent name
Wittkopp, Alexander
Krka, d.d., Novo mesto
Board
3.3.07
Headnote
-
Keywords
Sufficiency of disclosure - proof of the claimed therapeutic effect
Sufficiency of disclosure - post-published evidence
Sufficiency of disclosure - (yes)
Novelty - (yes)
Inventive step - reasonable expectation of success (no)
Amendments - added subject-matter (no)
Catchword
-
Citing cases
-

Order

For these reasons it is decided that:

The appeals are dismissed.